Linked Life Data

17911180

Source:http://linkedlifedata.com/resource/pubmed/id/17911180

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-12-24
pubmed:abstractText
We reported previously that N-myc downstream-regulated gene 2 (NDRG2), a member of a new family of differentiation-related genes, is expressed specifically in dendritic cells (DC) differentiated from monocytes, CD34(+) progenitor cells, and the myelomonocytic leukemic cell line. In this study, we demonstrate that NDRG2 protein expression is detected, not only in in vitro-differentiated DC but also in primary DC from lymph nodes, thymus, and skin when anti-NDRG2 antibodies are used. As predicted from previous studies investigating the mRNA expression pattern of several types of cell lines, progenitor cells, and DC, NDRG2 protein was expressed strongly in DC. Its expression was detected at significant levels after differentiation from progenitor cells. RNA interference of NDRG2 demonstrated that activated leukocyte cell adhesion molecule (ALCAM) expression is down-regulated specifically in DC differentiated from NDRG2 small interfering RNA (siRNA)-transfected monocytes. This was consistent with our observation that U937 cells transfected with NDRG2 became resistant to the GM-CSF/IL-4-induced ALCAM reduction. Furthermore, DC, which had differentiated from NDRG2 siRNA-transfected monocytes, showed a reduced ability to induce T cell proliferation. Taken together, our results indicate that NDRG2 is able to preserve ALCAM expression during DC differentiation from monocytes under cytokine culture conditions and that its expression helps DC maintain costimulatory signals necessary for T cell stimulation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0741-5400
pubmed:author
pubmed:issnType
Print
pubmed:volume
83
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
89-98
pubmed:meshHeading
pubmed-meshheading:17911180-Activated-Leukocyte Cell Adhesion Molecule, pubmed-meshheading:17911180-Cell Differentiation, pubmed-meshheading:17911180-Dendritic Cells, pubmed-meshheading:17911180-Down-Regulation, pubmed-meshheading:17911180-Gene Expression Profiling, pubmed-meshheading:17911180-Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:17911180-Humans, pubmed-meshheading:17911180-Immunohistochemistry, pubmed-meshheading:17911180-Interleukin-4, pubmed-meshheading:17911180-Lymph Nodes, pubmed-meshheading:17911180-Myeloid Cells, pubmed-meshheading:17911180-RNA, Messenger, pubmed-meshheading:17911180-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:17911180-Skin, pubmed-meshheading:17911180-T-Lymphocytes, pubmed-meshheading:17911180-Thymus Gland, pubmed-meshheading:17911180-Tumor Suppressor Proteins
pubmed:year
2008
pubmed:articleTitle
Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity.
pubmed:affiliation
Laboratory of Cell Biology, Korea Reseach Institute of Bioscience and Biotechnology, Daejeon, Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't